Cancer Diagnosis clinical trials

Explore recruiting cancer diagnosis clinical trials.

Recruiting cancer diagnosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cancer Diagnosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III b randomized open-label trial on metformin for cancer prevention in adolescents and adults with Li-Fraumeni syndrome (LFS)

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

The role of Contrast-Enhanced Spectral Mammography (CESM) in the diagnostic process of breast cancer: can it improve specificity of first-line examinations and therefore reduce the suspicious lesions that undergo vacuum assisted breast biopsy (VABB)?

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

"INDIGO-FAPI": Cutting Edge Imaging for Earlier Pancreatic Cancer Diagnosis: evaluation of Positron Emission Tomography (PET) with the Fibroblast Activation Protein Inhibitor (FAPI)

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Screening for occult malignancy using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in patients with unprovoked venous thromboembolism

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

CAPSI - Cancer related major depression treated with a single dose of psilocybin - a multicenter randomized placebo controlled double blind clinical trial

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label phase 2/3 study to analyse the feasibility and evaluate the safety of intravenous administration of 99mTc-PSMA-T4 in patients with prostate cancer

Poland

Phase II and Phase III (Integrated) EU CTIS Study details

Cancer Diagnosis trials by city

Cancer Diagnosis in Toronto Cancer Diagnosis in Vancouver Cancer Diagnosis in Montreal Cancer Diagnosis in Calgary Cancer Diagnosis in Edmonton Cancer Diagnosis in Ottawa Cancer Diagnosis in Winnipeg Cancer Diagnosis in Quebec City Cancer Diagnosis in Hamilton Cancer Diagnosis in Kitchener Cancer Diagnosis in London Cancer Diagnosis in Halifax Cancer Diagnosis in New York Cancer Diagnosis in Los Angeles Cancer Diagnosis in Chicago Cancer Diagnosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease